Myriad Genetics, Inc. (MYGN)
3.18
-0.04
(-1.24%)
USD |
NASDAQ |
Sep 01, 16:00
3.18
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Free Cash Flow : -14.20M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.20M |
| March 31, 2026 | -23.20M |
| December 31, 2025 | -25.60M |
| September 30, 2025 | -29.50M |
| June 30, 2025 | -50.00M |
| March 31, 2025 | -35.80M |
| December 31, 2024 | -38.40M |
| September 30, 2024 | -107.30M |
| June 30, 2024 | -141.30M |
| March 31, 2024 | -154.70M |
| December 31, 2023 | -184.20M |
| September 30, 2023 | -138.30M |
| June 30, 2023 | -118.90M |
| March 31, 2023 | -156.20M |
| December 31, 2022 | -152.30M |
| September 30, 2022 | -143.30M |
| June 30, 2022 | -165.40M |
| March 31, 2022 | -117.30M |
| December 31, 2021 | -1.00M |
| September 30, 2021 | 38.90M |
| June 30, 2021 | 95.00M |
| March 31, 2021 | 98.60M |
| June 30, 2020 | 49.50M |
| March 31, 2020 | 53.00M |
| December 31, 2019 | 42.70M |
| Date | Value |
|---|---|
| September 30, 2019 | 83.00M |
| June 30, 2019 | 75.10M |
| March 31, 2019 | 91.10M |
| December 31, 2018 | 96.20M |
| September 30, 2018 | 92.10M |
| June 30, 2018 | 107.50M |
| March 31, 2018 | 97.30M |
| December 31, 2017 | 128.30M |
| September 30, 2017 | 126.40M |
| June 30, 2017 | 100.10M |
| March 31, 2017 | 100.50M |
| December 31, 2016 | 122.20M |
| September 30, 2016 | 133.00M |
| June 30, 2016 | 161.30M |
| March 31, 2016 | 174.05M |
| December 31, 2015 | 138.17M |
| September 30, 2015 | 145.02M |
| June 30, 2015 | 116.60M |
| March 31, 2015 | 103.87M |
| December 31, 2014 | 88.14M |
| September 30, 2014 | 86.20M |
| June 30, 2014 | 175.94M |
| March 31, 2014 | 199.84M |
| December 31, 2013 | 225.96M |
| September 30, 2013 | 198.82M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Natera, Inc. | 51.20M |
| Sera Prognostics, Inc. | -28.18M |
| BioRestorative Therapies, Inc. | -11.90M |
| CareDx, Inc. | 84.03M |
| Exagen, Inc. | -7.588M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.30M |
| Cash from Investing (Quarterly) | -3.20M |
| Cash from Financing (Quarterly) | 2.20M |
| Free Cash Flow Per Share (Quarterly) | -0.1213 |
| Free Cash Flow to Equity (Quarterly) | -10.50M |
| Free Cash Flow to Firm (Quarterly) | -7.342M |
| Free Cash Flow Yield | -4.76% |